InVentiv focuses on product launches; Merck, Novo join TransCelerate;

> InVentiv Health's Campbell Alliance consulting business is offering a new service devoted to product launches. More

> Merck ($MRK) and Novo Nordisk ($NVO) have joined TransCelerate BioPharma, a group of major drugmakers united to improve how the industry conducts R&D. News

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.